Literature DB >> 12501858

Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study.

Makoto Yoshiba1, Kazuhiko Sekiyama, Kazuaki Inoue, Masaya Yamada, Makoto Kako, Kozo Nagai, Masao Takatori, Shogo Iwabuchi, Yasukiyo Sumino, Katsuaki Tanaka, Yukiya Hakozaki, Kiyoshi Hasegawa, Akitaka Shibuya.   

Abstract

BACKGROUND: We have attempted to predict the development of fulminant hepatic failure at the stage of severe acute hepatitis before the onset of coma. This prediction is valuable because it may be used to block the development of fulminant hepatic failure with appropriate medical treatment.
METHODS: To establish a discrimination formula, we retrospectively compared 13 clinical and laboratory variables in 36 patients with acute viral hepatitis and prothrombin levels of 40% or less of the control value who later developed fulminant hepatic failure with these variables in 12 patients who recovered spontaneously. A prospective study of 58 patients who developed fulminant hepatic failure and 18 who spontaneously recovered confirmed the validity of this formula.
RESULTS: In the retrospective study,we established the following discrimination equation: Z = -0.89 + 1.74 x (causal viruses, 1 point for type A or type B in acute hepatitis B virus [HBV] infection, 2 points for others) + 0.056 x (total bilirubin, mg/dl)-0.014 x (cholinesterase, U/ml). A positive Z value indicates that fulminant hepatic failure will develop. In the prospective study, the specificity, sensitivity, predictive accuracy, and positive and negative predictive values were 0.833, 0.983, 0.947, 0.950, and 0.938, respectively.
CONCLUSIONS: The present study indicated that fulminant hepatic failure can be predicted, by a simple discrimination equation, at the stage of severe acute hepatitis.

Entities:  

Mesh:

Year:  2002        PMID: 12501858     DOI: 10.1007/s005350200154

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  6 in total

Review 1.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

2.  Serum Procalcitonin in Patients with Acute Liver Failure.

Authors:  Takaaki Sugihara; Masahiko Koda; Toshiaki Okamoto; Kenichi Miyoshi; Tomomitsu Matono; Kenji Oyama; Keiko Hosho; Jun-Ichi Okano; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

3.  Dynamic changes of serum cholinesterase activity after severe trauma.

Authors:  Li Ba; Ding-qian Wu; An-yu Qian; Mao Zhang; Bing Xiong
Journal:  J Zhejiang Univ Sci B       Date:  2014-12       Impact factor: 3.066

4.  [Clinical and laboratory characteristics of juvenile myelomonocytic leukemia].

Authors:  Yuan-Yuan Wu; Sheng-Yang Cai; Wei Huang; Si-Si Li; Wei Li; Ao Dong
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

5.  An intensive medical care network led to successful living-donor liver transplantation in late-onset hepatic failure with disseminated Staphylococcus aureus infection.

Authors:  Rie Kure; Natsumi Uehara; Kazuaki Inoue; Tomomi Kogiso; Kazuhisa Kodama; Makiko Taniai; Katsutoshi Tokushige; Masayuki Nakano; Hiroto Egawa; Masakazu Yamamoto
Journal:  Clin J Gastroenterol       Date:  2018-09-14

6.  Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF.

Authors:  Zhe-Bin Wu; Yu-Bao Zheng; Ke Wang; Zhi-Shuo Mo; Xu Zhen; Ying Yan; Zhi-Liang Gao
Journal:  Can J Gastroenterol Hepatol       Date:  2021-11-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.